UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061592
Receipt number R000068176
Scientific Title Translation into Japanese and Examination of the Reliability and Validity of the Drinking Task Assessment
Date of disclosure of the study information 2026/08/01
Last modified on 2026/05/15 23:22:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Translation into Japanese and Examination of the Reliability and Validity of the Drinking Task Assessment

Acronym

Translation into Japanese and Examination of the Reliability and Validity of the Drinking Task Assessment

Scientific Title

Translation into Japanese and Examination of the Reliability and Validity of the Drinking Task Assessment

Scientific Title:Acronym

Translation into Japanese and Examination of the Reliability and Validity of the Drinking Task Assessment

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A culturally validated Japanese version of the Drinking Task Assessment (DTA) has not yet been developed, limiting its implementation in clinical settings in Japan. This study aims to develop a Japanese version of the DTA that maintains the conceptual integrity of the original while ensuring cultural appropriateness and semantic equivalence. Furthermore, by examining its reliability and validity, the study seeks to contribute to the standardization of upper limb function assessment and the advancement of physical therapy practice.

Basic objectives2

Others

Basic objectives -Others

The reliability and validity of DTA

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

DTA

Key secondary outcomes

Fugl-Meyer Assessment-UE (FMA-UE), Mini Mental State Examination- Japanese


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Participants will be:Patients with first ever stroke sequelae,Aged between 18 and 90 years, At least 30 days post onset, Patients with hemiparesis, Patients with a Fugl Meyer Assessment of the Upper Extremity score of less than 66

Key exclusion criteria

The exclusion criteria are as follows:

Patients who are unable to follow the instructions necessary for the assessment

Patients with other upper limb disorders that may affect upper limb motor performance

Patients who are unable to perform the tasks even with visual correction such as glasses or contact lenses

Patients with a Mini-Mental State Examination Japanese (MMSE J) score of less than 20

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Toru
Middle name
Last name Nagao

Organization

Graduate School of Health Sciences, Kobe University

Division name

Department of Motor Function Disorder Science

Zip code

654-0142

Address

7-10-2 Tomogaoka, Suma-ku, Kobe, Hyogo, Japan

TEL

078-792-2555

Email

nagao@kobe-u.ac.jp


Public contact

Name of contact person

1st name Tomoda
Middle name
Last name Yukitaka

Organization

Graduate School of Health Sciences, Kobe University

Division name

Department of Motor Function Disorder Science

Zip code

6570061

Address

1788, kusakabe, Doujyou, Kita ward, Kobe, Japan

TEL

0789502622

Homepage URL


Email

198k211k@gsuite.kobe-u.ac.jp


Sponsor or person

Institute

Kosei Hospital

Institute

Department

Personal name

Yukitaka Tomoda


Funding Source

Organization

In the process of applying for Japanese Physical Therapy Association

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Gothenburg University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kose Hospiatal

Address

1788, Kusakabe, Doujyou, Kita ward, Kobe city

Tel

0789502622

Email

198k211k@gsuite.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

恒生病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results

DTA

Results date posted

2025 Year 10 Month 30 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The purpose of this study is to develop a Japanese version of the Drinking Task Assessment (DTA) for patients with post-stroke sequelae.
The study will be conducted at Kosei Hospital from December 2025 to May 2027.
Participants will include ten patients with post-stroke sequelae who are hospitalized at the study site.

Participant flow

patients who are more than 30 days post-stroke onset

Adverse events


Outcome measures

FMA-LE MMSE-J

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 10 Month 01 Day

Date of IRB

2026 Year 01 Month 05 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry

2027 Year 12 Month 31 Day

Date trial data considered complete

2027 Year 12 Month 31 Day

Date analysis concluded

2027 Year 12 Month 31 Day


Other

Other related information

A pilot study will be conducted using the Japanese version of the Fugl-Meyer Assessment (FMA).
Two evaluators will each assess one patient twice.
Subsequently, the reliability and validity of the assessment will be examined.


Management information

Registered date

2026 Year 05 Month 15 Day

Last modified on

2026 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068176